Evaluate and Address Irritability as a Known Side Effect of Intuniv
The irritability your 8-year-old is experiencing is a recognized adverse effect of Intuniv (guanfacine extended-release), and you should contact the prescribing physician to discuss dose adjustment or gradual discontinuation rather than continuing at the current dose. 1, 2
Why This Is Happening
Irritability is explicitly listed as a known adverse effect of guanfacine extended-release in both the FDA label and clinical practice guidelines 1, 2. The AAP guidelines specifically note that "irritability, headache, bradycardia, hypotension, and abdominal pain" are documented side effects of extended-release guanfacine 1. This is not a rare occurrence—it's a recognized pattern that clinicians must monitor.
What You Should Do Now
Contact the prescribing physician within 1-2 days to report these symptoms. Do not stop the medication abruptly, as the FDA label warns that "rebound hypertension after abrupt guanfacine discontinuation has been observed" and emphasizes these medications "should be tapered off rather than suddenly discontinued" 1, 2.
Clinical Decision Points
The physician will likely consider these options in order:
Dose reduction: Since your child has been on 2mg for a year with good ADHD control, reducing to 1mg may eliminate irritability while maintaining some benefit. Clinical trials showed efficacy even at 1mg doses in children within the appropriate weight range 2.
Gradual taper and discontinuation: If irritability persists at lower doses or significantly impacts quality of life, taper off guanfacine completely over 1-2 weeks 1, 2.
Switch to alternative medication: Consider either:
Important Context About Timing
The fact that this emerged after one year of stable treatment is significant. While most adverse effects of guanfacine (somnolence, sedation, fatigue) typically emerge within the first 2 weeks and resolve by study end 3, 4, irritability can persist or emerge later. Research shows that 80% of patients on guanfacine experience at least one treatment-emergent adverse event 5.
Critical Safety Point
Do not attempt to manage this on your own by stopping the medication suddenly. The rebound hypertension risk is real and documented in the FDA label 1, 2. Even though your child is taking it at bedtime with Concerta in the morning, abrupt discontinuation carries cardiovascular risks that require medical supervision.
What to Monitor While Waiting
Until you speak with the physician, document:
- Specific times of day when irritability is worst
- Whether emotional symptoms worsen as the day progresses (suggesting medication wearing off vs. being present)
- Any changes in sleep, appetite, or blood pressure if you can check it at home
The combination of Intuniv 2mg at bedtime with Concerta 18mg in the morning was working well for ADHD control, but quality of life and emotional well-being take priority over symptom control alone—this is why the irritability must be addressed rather than tolerated 1.